Loading clinical trials...
Loading clinical trials...
Nonalcoholic fatty liver disease (NAFLD) is an emerging health problem as it can lead to end stage liver failure and cardiovascular complications. Diet play an important role in the development of NAF...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Maastricht University Medical Center
NCT05543083 · Insulin Resistance, Depression, and more
NCT07518784 · MASLD, MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease), and more
NCT05939934 · Sleep Apnea, Obstructive, Endothelial Dysfunction
NCT07487363 · Atherosclerotic Cardiovascular Diseases, Endothelial Dysfunction
NCT07460960 · Erectile Dysfunction Due to Arterial Disease, Atheroscleroses, and more
Maastricht University Medical Center
Maastricht, Limburg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions